BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15223167)

  • 1. Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.
    Huang Z; Zheng Y; Wen W; Wu C; Bao P; Wang C; Zhong W; Gao YT; Jin F; Xiang YB; Shu XO; Beeghly-Fadiel A
    Eur J Cancer; 2016 Aug; 63():1-10. PubMed ID: 27254837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    Liu Y; Shi W; Mubarik S; Wang F
    BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    Medhin LB; Tekle LA; Achila OO; Said S
    Sci Rep; 2020 Jun; 10(1):9099. PubMed ID: 32499531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).
    Joachim C; Véronique-Baudin J; Desroziers L; Chatignoux É; Belliardo S; Plenet J; Macni J; Ulric-Gervaise S; Peruvien J; Bhakkan-Mambir B; Deloumeaux J
    BMC Cancer; 2020 Jul; 20(1):643. PubMed ID: 32650744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
    Nakai H; Higashi T; Kakuwa T; Matsumura N
    Int J Clin Oncol; 2024 Apr; 29(4):363-371. PubMed ID: 38381162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of breast and gynaecological cancers by ethnic group in England, 2001-2007: a descriptive study.
    Shirley MH; Barnes I; Sayeed S; Finlayson A; Ali R
    BMC Cancer; 2014 Dec; 14():979. PubMed ID: 25522857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions.
    Llanos AAM; Warner WA; Luciani S; Lee TY; Bajracharya S; Slovacek S; Roach V; Lamont-Greene M
    Cancer Causes Control; 2017 Nov; 28(11):1251-1263. PubMed ID: 28917021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.
    Yun BS; Park EH; Ha J; Lee JY; Lee KH; Lee TS; Lee KJ; Kim YJ; Jung KW; Roh JW
    Obstet Gynecol Sci; 2023 Nov; 66(6):545-561. PubMed ID: 37953552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large Publication Gap for Gynecologic Cancers in High-Impact Factor Journals.
    Sinha N; McDonald A; Barry D; Barber EL
    Obstet Gynecol; 2023 Sep; 142(3):467-475. PubMed ID: 37535969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in screening and diagnostic lab-on-chip tools for gynaecological cancers - a review.
    Nujhat S; Leese HS; Di Lorenzo M; Bowen R; Moise S
    Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):618-629. PubMed ID: 37933813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional penalized splines for survival models: illustration for net survival trend analyses.
    Dantony E; Uhry Z; Fauvernier M; Coureau G; Mounier M; Trétarre B; Molinié F; Roche L; Remontet L
    Int J Epidemiol; 2024 Feb; 53(2):. PubMed ID: 38499394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
    Giudici F; De Paoli A; Toffolutti F; Guzzinati S; Francisci S; Bucchi L; Gatta G; Demuru E; Mallone S; Cin AD; Caldarella A; Cuccaro F; Migliore E; Gambino ML; Ravaioli A; Puppo A; Ferrante M; Carrozzi G; Stracci F; Musolino A; Gasparotti C; Cavallo R; Mazzucco W; Vitale MF; Cascone G; Ballotari P; Ferretti S; Mangone L; Rizzello RV; Sampietro G; Mian M; Boschetti L; Galasso R; Bella F; Piras D; Sessa A; Seghini P; Fanetti AC; Pinna P; De Angelis R; Serraino D; Maso LD; Working Group A
    Am J Epidemiol; 2024 Apr; ():. PubMed ID: 38629583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging epidemic of endometrial cancer: Time to take action.
    Crosbie E; Morrison J
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):ED000095. PubMed ID: 25549990
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in gynecologic cancer mortality in East Asian regions.
    Lee JY; Kim EY; Jung KW; Shin A; Chan KK; Aoki D; Kim JW; Low JJ; Won YJ
    J Gynecol Oncol; 2014 Jul; 25(3):174-82. PubMed ID: 25045429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy.
    Giorgi Rossi P; Ricciardi A; Cohet C; Palazzo F; Furnari G; Valle S; Largeron N; Federici A
    BMC Public Health; 2009 Feb; 9():71. PubMed ID: 19243586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis.
    Stracci F; Canosa A; Minelli L; Petrinelli AM; Cassetti T; Romagnoli C; La Rosa F
    BMC Cancer; 2007 Jan; 7():10. PubMed ID: 17227578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Danish cancer patients 1943-1987. Female genital organs.
    Kjaer SK; Storm HH
    APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.